Vivos Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vivos Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $250.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $2.24M.
- Vivos Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $796.07K.
- Vivos Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $25.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $796.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $250.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.24M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $25.00K 10-K · filed 2026-04-15 | |
| 2020-12-31 | $796.00K 10-K · filed 2022-03-31 | |
| 2020-03-31 | $796.07K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |